PD-1/PD-L1 pathway and angiogenesis dual recognizable nanoparticles for enhancing chemotherapy of malignant cancer

Although the cancer immunotherapy represents one of the most promising strategies for cancer treatment, the PD-1/PD-L1 pathway, which involves a receptor-ligand interaction, can induced immunosuppression by disabling tumor-infiltrating lymphocytes (TILs). In the present study, we coupled a PD-L1 (Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhenliang, Zhang, Yang, Cao, Duo, Wang, Xufeng, Yan, Xuebing, Li, Hao, Huang, Linsheng, Qu, Xiao, Kong, Cheng, Qin, Huanglong, Wang, Man, Xu, Wei, Liang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225483/
https://www.ncbi.nlm.nih.gov/pubmed/30394118
http://dx.doi.org/10.1080/10717544.2018.1509907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225483/
https://www.ncbi.nlm.nih.gov/pubmed/30394118
http://dx.doi.org/10.1080/10717544.2018.1509907

Ejemplares similares